1. Endoscopic Third Ventriculostomy: The Lebanese Experience
- Author
-
G. Nohra, Rudy J. Rahme, Elie Samaha, N Okais, Ralph Rahme, Ronald Moussa, T. Rizk, and Roula Hourani
- Subjects
Adult ,Male ,medicine.medical_specialty ,Adolescent ,MEDLINE ,Obstructive hydrocephalus ,Kaplan-Meier Estimate ,Ventriculostomy ,Young Adult ,Risk Factors ,medicine ,Humans ,Lebanon ,Young adult ,Cerebellar Neoplasms ,Child ,Aged ,Retrospective Studies ,Third Ventricle ,business.industry ,Follow up studies ,Endoscopic third ventriculostomy ,Infant ,Endoscopy ,Retrospective cohort study ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,Surgery ,Neuroendoscopy ,Aqueductal stenosis ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Female ,sense organs ,Neurology (clinical) ,Morbidity ,business ,Pinealoma ,Follow-Up Studies ,Hydrocephalus ,Medulloblastoma - Abstract
Background: Endoscopic third ventriculostomy (ETV) has gained wide popularity as a first-line treatment for obstructive hydrocephalus (OHC). We have been performing ETV since 1998. We report our experience with this technique in the management of OHC. Methods: Between 1998 and 2007, we performed 49 ETV procedures in 46 patients suffering from OHC. Medical records were retrospectively reviewed. Success was defined as shunt-free survival. Results: There were 29 males and 17 females with a mean age of 23 years (6 months–65 years). Aqueductal stenosis and tectal tumor were the most common etiologies (63%). Seven patients (15.6%) had early ETV failure. Of 38 patients with initial success and available follow-up, shunt independence was achieved in 29 patients (76.3%) after a mean follow-up of 37 months. Kaplan-Meier analysis yielded a 70% 5-year shunt-free survival rate. On multivariate analysis, no variables could predict early or late ETV failure. Transient complications occurred in 6 patients (13%), but there were no ETV-related deaths or permanent morbidity. Conclusion: ETV is a safe and effective treatment for OHC, resulting in a high rate of long-term shunt independence with a low risk of complications. ETV should be considered the treatment of choice for patients with OHC and its development as a substitute to shunt placement should be encouraged in neurosurgically developing countries.
- Published
- 2009
- Full Text
- View/download PDF